Mainz Biomed Stock (NASDAQ:MYNZ), Trade Ideas

Mainz Biomed

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.

News

Penny Stocks

Markets

Trading Ideas

MRNA

MYNZ

Bristol Myers Squibb (NYSE: BMY), Merck &amp; Co Inc (NYSE: MRK), Pfizer Inc (NYSE: PFE) and Johnson &amp; Johnson(NYSE: 

The Pharmaceutical Industry Finds Itself At A Historical Crossroads

Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) did not only earn billions of dollars from their COVID-19 leading products but also rose to fame for saving the world from an unforeseen pandemic.

Pharma&#39;s Post-Pandemic Story To Unlock A Cancer-Free Era

Health Care

Tech

General

When it comes to cancer, one cannot overestimate the importance of early detection. Especially when it comes to colorectal and endometrial cancer that even big pharma companies don’t have a good track record at treating.

Gynecology Plays A Pivotal Role In Colorectal and Endometrial Cancer Screening

Mainz Biomed NV

Rush Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUSHA#NASDAQ">RUSHA</a>) reported quarterly earnings of $0.88 per share which beat the analyst consensus estimate of $0.77 by 14.29 percent. This is a 17.76 percent decrease over earnings of $1.07 per share from the same period last year. The company reported quarterly sales of $1.872 billion which met the analyst consensus estimate. This is a 2.09 percent decrease over sales of $1.912 billion the same period last year.

Earnings

Earnings Beats

RUSHA

Rush Enterprises Q1 2024 GAAP EPS $0.88 Beats $0.77 Estimate, Sales $1.872B Inline

Rush Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUSHB#NASDAQ">RUSHB</a>) reported quarterly earnings of $0.88 per share which beat the analyst consensus estimate of $0.82 by 7.32 percent. The company reported quarterly sales of $1.872 billion which missed the analyst consensus estimate of $1.882 billion by 0.53 percent. This is a 2.09 percent decrease over sales of $1.912 billion the same period last year.

Earnings Misses

RUSHB

Rush Enterprises Q1 2024 GAAP EPS $0.88 Beats $0.82 Estimate, Sales $1.872B Miss $1.882B Estimate

Guidance

TSLA

Tesla CEO Musk Says Thinks They Will Have Higher Sales This Year Than Last Year

Tesla CEO Musk Says Company Constitutes Majority Of His Work Time

<h1 class="wp-block-heading">Top Stories for April 23, 2024:</h1>
<ol>
<li>Cleveland-Cliffs Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) reported <a href="https://www.benzinga.com/wiim/24/04/38378385/cleveland-cliffs-shares-are-trading-lower-after-the-companys-reported-worse-than-expected-q1-financi">first-quarter results</a>, including revenue of $5.2 billion, a net loss of $53 million and adjusted net income of $87 million. </li>
</ol>
Adjusted EBITDA reached $414 million, marking a significant year-over-year and quarter-over-quarter improvement.
The company announced the completion of a previous $1 billion share repurchase program, having bought back 30.4 million shares. It also introduced a new $1.5 billion share buyback initiative.&nbsp;
Steel shipments totaled 3.9 million net tons and the firm retired all remaining secured notes to enhance its liquidity position, which stood at $4 billion at the end of March 2024.
<ol start="2">
<li>Freeport-McMoRan Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>) reported strong first-quarter 2024 results with copper sales and unit net cash costs surpassing estimates from January 2024 and the first quarter of 2023. </li>
</ol>
Net income reached $473 million, with consolidated sales of 1.1 billion pounds of copper, 568 thousand ounces of gold and 20 million pounds of molybdenum.&nbsp;
Indonesia smelter projects are close to completion and expected to start in the second quarter of 2024. 
The company&#8217;s operating cash flows totaled $1.9 billion and capital expenditures were $1.3 billion for the quarter.&nbsp;
Kathleen L. Quirk will become CEO on June 11, 2024, succeeding Richard C. Adkerson.
Also Read:<a href="https://www.benzinga.com/topic/mining"> </a><a href="https://www.benzinga.com/news/large-cap/24/04/38364875/geopolitical-relief-triggers-gold-selloff-prices-dip-below-2-350-mark-mining-stocks-hit-hard">Geopolitical Relief Triggers Gold Selloff: Prices Dip Below $2,350 Mark, Mining Stocks Hit Hard</a>
<ol start="3">
<li>Worthington Steel Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WS#NYSE">WS</a>) was honored as a General Motors Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) Supplier of the Year for the third time, previously winning in 2020 and 2021. </li>
</ol>
GM recognized 86 suppliers for their 2023 performance, emphasizing three core values: safety, inclusion and relationships. The award celebrates suppliers who contribute to GM's goals of innovation and high-quality vehicle production.&nbsp;
Worthington Steel provides flat-roll carbon steel coils used in GM&#8217;s vehicle production across facilities in Indiana, Michigan, Ohio and Mexico.
<ol start="4">
<li>Metals Acquisition Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTAL#NYSE">MTAL</a>) released its Resource and Reserve Statement and three-year production guidance for the CSA Copper Mine, highlighting significant growth in resources and mine life. </li>
</ol>
Key updates include an extended mine life of 11 years up to 2034, a 67% increase from last year, and a 64% increase in contained copper to 0.5 million tons.&nbsp;
The measured and indicated mineral resources have risen to 229,000 tons of copper, with an additional 184,000 tons classified as inferred.&nbsp;
These enhancements occurred just 10 months post-acquisition, with continued drilling aimed at further expanding resources.
Now Read:<a href="https://www.benzinga.com/"> </a><a href="https://www.benzinga.com/m-a/24/04/38380999/exclusive-why-this-uranium-bull-market-is-different-weve-really-got-to-start-developing-mines-says-m">EXCLUSIVE: Why This Uranium Bull Market Is Different — &#8216;We&#8217;ve Really Got To Start Developing Mines,&#8217; Says Madison Metals CEO</a>
Benzinga Mining is the bridge between mining companies and retail investors. Reach out to <a href="mailto:licensing@benzinga.com">licensing@benzinga.com</a> to get connected with the Benzinga community!
Photo: Shutterstock

Commodities

MTAL

Cleveland-Cliffs, Freeport-McMoRan Report Q1 Results; Worthington Steel Gets GM Supplier Of The Year And More: Tuesday's Top Mining Stories

Tesla CEO Musk Says In Conversations With One Major Automaker Regarding Licensing FSD

WIIM

CSGP

CoStar Group shares are trading higher after the company reported better-than-expected Q1 financial results.

Flushing Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIC#NASDAQ">FFIC</a>) reported quarterly earnings of $0.14 per share which met the analyst consensus estimate. This is a 133.33 percent increase over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $45.481 million which missed the analyst consensus estimate of $48.286 million by 5.81 percent. This is a 12.82 percent decrease over sales of $52.170 million the same period last year.

FFIC

Flushing Financial Q1 2024 GAAP EPS $0.14, Inline, Sales $45.481M Miss $48.286M Estimate

Tesla CEO Musk Says May Be Able To Sell Optimus By End Of Next Year

Tesla CEO Musk Says Tesla Will Have 85,000 Nvidia H100 GPUS Training AI By End Of Year

<a href="https://www.sec.gov/Archives/edgar/data/1620704/000147793224002292/medx_rw.htm" title="https://www.sec.gov/Archives/edgar/data/1620704/000147793224002292/medx_rw.htm">https://www.sec.gov/Archives/edgar/data/1620704/000147793224002292/medx_rw.htm</a>

IPOs

Med-X Withdraws IPO Plan; Elects Not To Pursue Sale Of Securities At This Time - Filing

A substantial slowdown in the shipping business caused United Parcel Service, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) <a href="https://www.benzinga.com/news/earnings/24/04/38376943/ups-delivers-mixed-bag-of-q1-results-maintains-guidance-despite-lower-volumes">to deliver lackluster first-quarter results on Tuesday</a>.
When compared to the same period last year, revenue declined 5.3% and operating profit was down 31.5% when adjusting for inflation.&nbsp;
The large drop in operating profit stems from <a href="https://www.benzinga.com/news/large-cap/23/08/33995076/ups-and-teamsters-seal-the-deal-ensures-170-000-per-year-for-drivers-the-next-5-years">recent salary negotiations between UPS and the Teamsters</a>, the labor union that represents the company's employees.&nbsp;
The historic wage negotiation closed last August and hit the UPS balance sheet by guaranteeing a $170,000 salary for delivery truck drivers over the next five years. Negotiations affect 340,000 UPS teamsters with higher wages and overall better working conditions, <a href="https://www.benzinga.com/news/23/08/34101423/drop-off-your-old-gig-pick-up-this-pay-package-ups-drivers-make-170k-under-new-deal">making the $170k salary the new average for UPS employees</a>.
Nonetheless, shares of the company were up by 2.4% as Tuesday progressed, as quarterly profit beat analyst expectations, although they were on the decline for five consecutive quarters.
The company is boasting several positive news from recent times, including <a href="https://www.benzinga.com/news/24/04/38086914/postal-services-air-cargo-shift-to-ups-makes-everyone-a-winner">a new contract with the United States Postal Service (USPS) to provide air cargo services</a>.
The USPS dropped FedEx Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) earlier this month as its main domestic air carrier, deciding not to renew a contract worth $1.5 billion, and choosing UPS instead. The new contract will go on at least for five-and-a-half years and have UPS as the primary contractor for the USPS' first-class mail, priority mail and priority express mail.
Read also: <a href="https://www.benzinga.com//node/38029989">UPS Vs. FedEx: Which Stock Boasts A Higher Upside? Here&#8217;s What Analysts Say</a>
The shift was considered a win-win for both competitors, as FedEx is looking to reduce its operations and take out $4 billion in structural costs by the end of fiscal year 2025.
On its previous quarterly call, UPS CEO Carol Tomé called 2023 "a difficult and disappointing year." The company experienced declines in volume, revenue, and operating profit in all three of its business segments, <a href="https://www.benzinga.com/news/earnings/24/01/36866048/these-analysts-cut-their-forecasts-on-ups-following-q4-results">causing analysts to cut their forecasts</a>.
Tomé blamed the macro environment, as well as the new employee deal as reasons behind recent drops in revenue.
This time, the executive showcased a more hopeful attitude. While average daily volume continued to decline, the rate of decline was slower in the first quarter both domestically and internationally.
To compensate for the decline in volume, the company announced earlier this year <a href="https://www.benzinga.com/news/earnings/earnings-misses/24/01/36849715/ups-slashes-12-000-jobs-in-cost-cutting-move-shares-plunge">plans to shed 12,000 positions, representing about 14% of its managerial workforce</a>, potentially saving the company $1 billion in 2024.
Tomé is expecting the USPS deal to bring in at least part of the revenue the company needs to compensate for losses in volume. The CEO said the deal will contribute to top-line growth, fitting "beautifully with our strategy to grow our B2B business."
Now Read: <a href="https://www.benzinga.com//node/38223600">Retail Resilience: Wayfair, Lowe&#8217;s, Best Buy — JPMorgan&#8217;s Top Stock Picks</a>
Photo: Shutterstock

UPS Earnings Show The Weight Of $170,000 Salaries While It Learns To Navigate Shipping Slump

Tesla Says It Expect New Model Production To Start Early 2025 If Not Late This Year

The company expects total capital expenditures to range from&nbsp;$130&nbsp;-&nbsp;$150 million&nbsp;in 2024,&nbsp;$130&nbsp;-&nbsp;$150 million&nbsp;in 2025, and&nbsp;$100&nbsp;-&nbsp;$120 million&nbsp;in 2026.

WIRE

Encore Wire Says Remain Focused On Long-Term Opportunities For Its Business As It Continues To Address Near-Term Challenges

David Pecker, former head of the National Enquirer, testified Tuesday about his role in purchasing and suppressing stories to benefit Donald Trump during the 2016 presidential campaign, revealing details of his frequent communications with Trump and an unwritten agreement to publish favorable coverage of him while <a href="http://benzinga.com/general/politics/24/04/38366379/trump-committed-conspiracy-to-undermine-the-integrity-of-a-presidential-election-prosecution-all">targeting his political opponents.</a>
What Happened: During testimony Tuesday, Pecker shared details of the process of the National Enquirer buying stories <a href="http://benzinga.com/topic/donald-trump">related to Trump.</a>
Pecker said he previously bought stories from Trump based on "The Apprentice" in what he called a mutually beneficial relationship, NBC News <a href="https://www.nbcnews.com/politics/donald-trump/live-blog/trump-hush-money-live-updates-day-6-rcna148919">reported</a>.
The media mogul said interest in Trump "skyrocketed" after the success of "The Apprentice" and "Celebrity Apprentice."
Pecker said he previously spoke monthly or quarterly with Trump, and in some cases it was more frequent, depending on how much the former president was in the news. When Trump announced he was running for president in 2015, the two met more frequently.
Testimony about a 2015 meeting at Trump Tower between Trump, his former lawyer Michael Cohen and Pecker was a key part of the court proceedings on Tuesday. 
"Thinking about it as I did previously, I said what I would do is I would run or publish positive stories about Mr. Trump, and I would publish negative stories about his opponents," Pecker said. &nbsp;
The agreement was never put into writing, but was rather an agreement between friends, Pecker said Tuesday. Pecker added that running stories that were negative on the Clinton family often did well and pleased Cohen and Trump.
Pecker also said Cohen directed him to target certain 2016 presidential candidates with stories. This included running a story about 2016 Republican presidential candidate Ted Cruz.
The media mogul said that it was common for women to sell stories to the National Enquirer or to other outlets. Stories about Trump or the 2016 election had to be brought to Pecker at the time, according to company rules he put in place.
Stories then were sent from Pecker to Cohen to be vetted.
One story that was brought up in court Tuesday was one from Dino Sajudin, a doorman at Trump Tower. The doorman tried to sell a story about an illegitimate child from Trump and a maid who worked in the building.
Pecker recalled calling Cohen on the story who said it was not true. Pecker bought the story for $30,000 to make sure another publisher didn't get their hands on it.
"I made the decision to buy the story because of the potential embarrassment to the campaign and Mr. Trump."
Pecker said he didn't publish the story until after the 2016 presidential election based on a request from Cohen.
Pecker also said that a poll run by the National Enquirer saying 80% of readers wanted Trump to run for president was later cited by the former president as part of his reasoning for running.
Related Link: <a href="https://www.benzinga.com/general/politics/24/04/38326553/trump-hush-money-trial-has-12-jurors-here-are-the-7-men-5-women-to-decide-former-presidents-fate">Trump Hush Money Trial Has 12 Jurors: Here Are The 7 Men, 5 Women To Decide Former President&#8217;s Fate</a>
What's Next: Another key part of the testimony by Pecker was of a story of former Playboy model Karen McDougal alleging an affair with Trump.
Pecker also told the court that he spoke more often with Cohen after the McDougal story began circulating. Cohen instructed Pecker not to talk on a landline and to use messaging app Signal, where messages are automatically destroyed, Pecker recalled.
This happened at the end of Tuesday's session and will likely carry over into Thursday when the trial resumes.
On Tuesday morning ahead of testimony, Judge Juan Merchan heard from the prosecution and defense about a potential violation of <a href="https://www.benzinga.com/general/politics/24/03/37945216/trump-hit-with-gag-order-in-hush-money-case-his-statements-were-threatening-inflammatory-denigra">a gag order imposed</a> on Trump before the trial.
Merchan said he would "reserve a decision" on if Trump violated the gag order with posts on social media.
Speaking to media after the trial Tuesday, Trump said that Merchan has taken away his "constitutional right to free speech" with the gag order.
"This is a kangaroo court," Trump said on social media Tuesday. &nbsp;
Read Next: <a href="https://www.benzinga.com/general/politics/24/04/38279176/trump-hush-money-trial-draws-reaction-from-congressman-talk-show-hosts-worse-than-anything-richa">Trump Hush Money Trial Draws Reaction From Congressman, Talk Show Hosts: &#8216;Worse Than Anything Richard Nixon Ever Did&#8217;</a>
Photo: Shutterstock

Politics

Legal

David Pecker Testifies To National Enquirer Buying Stories That Could Damage Donald Trump: 'Potential Embarrassment To The Campaign'

First Busey (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BUSE#NASDAQ">BUSE</a>) reported quarterly earnings of $0.47 per share which missed the analyst consensus estimate of $0.49 by 4.08 percent. This is a 27.69 percent decrease over earnings of $0.65 per share from the same period last year. The company reported quarterly sales of $110.767 million which beat the analyst consensus estimate of $109.091 million by 1.54 percent. This is a 5.89 percent decrease over sales of $117.705 million the same period last year.

BUSE

First Busey Q1 2024 Adj EPS $0.47 Misses $0.49 Estimate, Sales $110.767M Beat $109.091M Estimate

SMFL

Smart for Life Completes Restructuring Program

Encore Wire (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WIRE#NASDAQ">WIRE</a>) reported quarterly earnings of $3.92 per share which beat the analyst consensus estimate of $3.65 by 7.4 percent. This is a 39.69 percent decrease over earnings of $6.50 per share from the same period last year. The company reported quarterly sales of $632.661 million which beat the analyst consensus estimate of $589.846 million by 7.26 percent. This is a 4.21 percent decrease over sales of $660.492 million the same period last year.

Encore Wire Q1 2024 GAAP EPS $3.92 Beats $3.65 Estimate, Sales $632.661M Beat $589.846M Estimate

This year&#39;s&nbsp;4/20 cannabis celebrations demonstrated not only a growth in consumer demand but also the crucial role of technology in understanding this surge. The overall week of 4/20 saw 3x the sales and units sold compared to any typical week.
<a href="https://www.benzinga.com/topic/treez">Treez</a>, a point-of-sale provider, reported a 120% increase in<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38344499/420-cannabis-retail-frenzy-leading-brands-ready-for-record-sales-surge-who-will-lea"> sales on 4/20</a> compared to the previous year, with a striking 200% increase the day before. This indicates consumers were preparing early for the festivities.
<h3>Transaction Data</h3>
<a href="https://feeds2.benzinga.com/topic/jane-technologies">Jane Technologies</a>, a leading digital provider for cannabis dispensaries, smoothly handled over half a million transactions, totaling $23,878,546.72 in sales.
Despite a minor 8% decrease from 2023&#39;s sales on the same day, the combined total for 4/19 and 4/20 reached a record $45,708,937.34, up 14.32% from the previous highest two-day total.
<h3>Sales Highlights</h3>
Illinois led state sales with $4,494,973.86, though slightly down from the previous year.
Sales figures from <a href="https://www.benzinga.com/markets/cannabis/24/04/38151565/californias-underground-marijuana-market-flourishes-which-companies-remain-resilient-amid-illici">California</a> and Colorado also highlighted significant market activity, with California recording $2,271,390.97 in sales and Colorado bringing in $671,307.73.
<h3>Pricing Online</h3>
According to <a href="https://www.benzinga.com/topic/weedmaps">Weedmaps</a>&nbsp;<a href="https://www.benzinga.com/topic/weedmaps">data</a>&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/maps#NASDAQ">MAPS</a>),<a href="https://www.benzinga.com/topic/weedmaps">&nbsp;</a>pricing trends on 4/20 in 2024 showed notable changes: the average price of vape pens decreased by 16% since 2021, and edibles saw a 21% reduction.
Conversely, the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38282615/cannabis-brands-leading-market-expansion-in-east-midwest-a-look-at-prices-and-trend">average price of flowers</a> on Weedmaps experienced a 5% year-over-year increase from 2023, although it remained 10% below 2021 levels.
Additionally, with 4/20 falling on a Saturday, order volumes surged earlier than typical, peaking around 11 a.m. PT.
This early peak was preceded by an 18% increase in orders on Friday, 4/19, compared to the average of the previous two Fridays in April, indicating an extended period of heightened activity.
<h3>Shifts In Consumer Preferences</h3>
The preference for <a href="https://www.benzinga.com/markets/cannabis/24/03/37949190/after-the-pre-roll-boom-whats-next-in-cannabis-products-the-secret-is-under-the-microscope">convenience </a>was apparent as, for the first time, pre-rolls tied with flowers, each accounting for 25% of total sales. This shift suggests consumers favor <a href="https://www.benzinga.com/analyst-ratings/analyst-color/23/11/35819064/ready-to-bake-optimize-cannabis-retail-sales-for-thanksgiving-with-bdsas-basket-ana">ready-to-use options</a> during significant cannabis holidays.
According to Jane Technologies, the top-selling product categories on 4/20 were led by flowers with sales reaching $9,388,597.82, followed by vapes at $6,216,507.58,<a href="https://www.benzinga.com/analyst-ratings/analyst-color/23/07/33369455/sweet-treats-take-over-gummie-consumption-outpaces-flower-in-latest-consumer-data-h"> edibles</a> totaling $3,234,281, pre-rolls at $2,098,248.69, and extracts with $1,419,352.37. The <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38386324/whos-winning-in-weed-analyst-looks-at-cannabis-markets-big-players-where-are-the-be">most popular brands</a> driving these sales included RYTHM, &amp;Shine, STIIIZY, Savvy, and Float.
Moreover, data from Weedmaps, which verifies retail cannabis products, showed that 72% of items ordered were brand-verified, pointing to a strong consumer preference for recognized and trusted brands.
<h3>Impact Of Discounts And Promotions</h3>
Promotional strategies were critical in driving sales, with Jane Technologies offering an average discount of 37% on 4/20.
Weedmaps recorded a 130% increase in deal redemptions during the week of 4/20 compared to the same period in 2023, emphasizing the effectiveness of discounts in boosting <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38343689/whats-the-net-worth-of-these-420-underdogs-mid-tier-cannabis-retailers-cultivators-">transaction volumes</a>.
<h3>Data-Driven Market Compasses</h3>
The extensive data provided by companies like Jane Technologies, Weedmaps&nbsp;and Treez underscores the expanding reach and acceptance of cannabis while highlighting the crucial contributions of data-driven platforms in the industry.
With ongoing technological advancements and strategic insights, the future of the cannabis industry appears to be increasingly driven by data, focusing on optimizing consumer experiences and market efficiencies.
Photo: AI-Generated Image.&nbsp;

Analyst Color

Cannabis

Entrepreneurship

Retail Sales

Management

Market-Moving Exclusives

Analyst Ratings

MAPS

After The 4/20 Smoke Clears: What Do The Billions Spent On Cannabis Say About Sales In Key States?

Trustmark (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRMK#NASDAQ">TRMK</a>) reported quarterly earnings of $0.68 per share which beat the analyst consensus estimate of $0.60 by 13.33 percent. This is a 17.07 percent decrease over earnings of $0.82 per share from the same period last year. The company reported quarterly sales of $191.544 million which beat the analyst consensus estimate of $189.232 million by 1.22 percent. This is a 0.47 percent decrease over sales of $192.449 million the same period last year.

TRMK

Trustmark Q1 2024 GAAP EPS $0.68 Beats $0.60 Estimate, Sales $191.544M Beat $189.232M Estimate

The market has been high on Mainz Biomed NV (MYNZ)  stock recently. MYNZ gets a Bullish score from InvestorsObserver Stock Sentiment Indicator. Mainz Biomed NV has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on MYNZ!See Full MYNZ ReportWhat is Stock Sentiment?Sentiment is

Is Mainz Biomed NV (MYNZ) a Stock to Watch After Gaining 18.18% This Week?

Mainz Biomed NV (MYNZ) stock is down -85.73% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserverâ€&#x2122;s proprietary ranking system, gives MYNZ stock a score of  35 out of a possible 100. That rank is mainly influenced by a long-term technical score of 4. MYNZ's rank also include

Mainz Biomed NV (MYNZ) Stock Declines -2.94% This Week; Should You Buy?

Mainz Biomed NV (MYNZ) stock has fallen 7.92% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator. Mainz Biomed NV has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on MYNZ!See Full MYNZ ReportWhat is Stock Sentiment?In investing, sentimen

Should You Buy Mainz Biomed NV (MYNZ) Stock on Monday?

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Iterum Therapeutics (ITRM – Research Report) and Mai...

Analysts Are Bullish on Top Healthcare Stocks: Iterum Therapeutics (ITRM), Mainz Biomed B.V. (MYNZ)

Mainz Biomed NV (MYNZ) is up Monday morning, with the stock climbing 8.25% in pre-market trading to 1.05. MYNZ's short-term technical score of 6 indicates that the stock has traded less bullishly over the last month than 94% of stocks on the market. In the Diagnostics and Research industry, which ranks 104 out of 146 indus

Mainz Biomed NV (MYNZ) Up 8.25% in Premarket Trading

Mainz Biomed NV (MYNZ) stock has gained 4.12% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator. Mainz Biomed NV has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on MYNZ!See Full MYNZ ReportWhat is Stock Sentiment?In investing, sentimen

Where Will Mainz Biomed NV (MYNZ) Stock Go Next After It Is Up 4.12% in a Week?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Mainz Biomed (NASDAQ:<a href="https://investorplace.com/stock-quotes/mynz-stock-quote/">MYNZ</a>) just reported results for the fourth quarter of 2023.<ul><li>Mainz Biomed reported earnings per share of -24 cents. This was above the analyst estimate for EPS of -32 cents.</li><li>The company reported revenue of $214,761.</li><li>This was 20.46% worse than the analyst estimate for revenue of $270,000.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/04/mynz-stock-earnings-mainz-biomed-for-q4-of-2023/">MYNZ Stock Earnings: Mainz Biomed Beats EPS, Misses Revenue for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

MYNZ Stock Earnings: Mainz Biomed Beats EPS, Misses Revenue for Q4 2023

Mainz Biomed B.V. (MYNZ) has disclosed a new risk, in the Cyber Security category. Mainz Biomed B.V. faces significant cybersecurity threats that c...

Mainz Biomed B.V. Confronts Escalating Cybersecurity Dangers Threatening Operations and Data Security

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Mainz Biomed B.V. (MYNZ – Research Report), Century ...

Analysts' Top Healthcare Picks: Mainz Biomed B.V. (MYNZ), Century Therapeutics (IPSC)

Mainz Biomed B.V. (MYNZ) has released an update. Mainz Biomed B.V. enters into a supplemental agreement with YA II PN, LTD., involving a third Pre-...